HOTH
Hoth Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.80
−2.22%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-162.4%
Return on equity
-139.0%
Return on assets
-160.6%
Return on invested capital
0.00x
Asset turnover
-$10.7M
Cash from operations
$0.41
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026